FDA
-
-
-
-
-
-
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Pacira BioSciences sues WhiteOak, Qilu over EXPAREL patent infringement
-
-
-
-
-
-
-
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
-
-
-
-
-
-
-
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
-
-
-
-
-
-
-
Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee
-
-
-
-
-
-
-
Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments
-
-
-
-
-
-
-
Pacira BioSciences (PCRX) Awarded New U.S. Patent Covering EXPAREL Composition
-
322,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

